Factor Bioscience Inc.
Cambridge, MA, US· latest recorded location
Factor Bioscience Inc. is named on 64 US grants and 85 published applications in this corpus. Its most frequent classification is C12N (Microorganisms or enzymes).
- Granted patents
- 64
- Published applications
- 85
- Inventors
- 14
- Granted in 2026 so far
- 2
- Most recent grant
- 15 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2013 | 1 | 2 |
| 2014 | 0 | 1 |
| 2015 | 1 | 3 |
| 2016 | 6 | 7 |
| 2017 | 7 | 7 |
| 2018 | 5 | 7 |
| 2019 | 8 | 10 |
| 2020 | 12 | 18 |
| 2021 | 3 | 5 |
| 2022 | 8 | 2 |
| 2023 | 3 | 9 |
| 2024 | 2 | 2 |
| 2025 | 6 | 3 |
| 2026 | 2 | 9 |
By publication year. 2026 runs to 8 Oct.
Technology areas
Share of 149 documents
- C12NMicroorganisms or enzymes138
- A61PTherapeutic uses of medicines131
- A61KMedicines and medical preparations120
- C12YEnzymes90
- C07KPeptides66
- G01NInvestigating or analysing materials by determining their chemical or physical properties38
- C08GMacromolecular compounds obtained otherwise than by reactions only involving unsaturated carbon-to-carbon bonds31
- C08KUse of inorganic or non-macromolecular organic substances as compounding ingredients31
- C12PFermentation or enzyme-using processes to synthesise a desired chemical compound or composition31
- H10FSolar cells and light sensors31
Recent patents
- Engineered gene-editing proteins15 Sep 2026US 12,735,687 B2
- Methods and products for transfecting cells24 Feb 2026US 12,559,772 B2
- Methods and products for transfecting cells19 Aug 2025US 12,391,961 B2
- Cationic lipids and transfection methods12 Aug 2025US 12,384,740 B2
- Cationic lipids and transfection methods1 Jul 2025US 12,344,572 B2
- Multivalent ionizable lipid delivery systems28 May 2026US 2026/0144753 A1
- Methods for reprogramming and gene editing cells28 May 2026US 2026/0146264 A1
- Methods and products for transfection30 Apr 2026US 2026/0117193 A1
- Methods for reprogramming and gene editing cells23 Apr 2026US 2026/0108554 A1
- Cationic lipids and uses thereof19 Mar 2026US 2026/0078081 A1
Most cited
By later US patents
- Methods and products for expressing proteins in cells33US 9,376,669 B22016
- Methods and products for expressing proteins in cells33US 9,464,285 B22016
- Methods and products for expressing proteins in cells31US 9,447,395 B22016
- Methods and products for expressing proteins in cells31US 9,487,768 B22016
- Nucleic acid products and methods of administration thereof28US 10,137,206 B22018